Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Dose Adjusted 5-FU in Metastatic Colorectal Cancer
NCT06501989Phase 2Withdrawn
- Sponsor
- Inova Health System
- Start
- Sep 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil in metastatic colorectal cancer (mCRC), sponsored by Inova Health System. Planned start Sep 2025; status: withdrawn.
02
Drugs
fluorouracil
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT06501989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06501989.